- Warfarin is a known teratogen and is generally avoided in pregnancy; first-trimester exposure can cause a pattern of birth defects sometimes called warfarin embryopathy, and there are bleeding risks to the baby later in pregnancy.
- Because of this, most people who need anticoagulation are switched, usually to heparin or low-molecular-weight heparin, which does not cross the placenta the way warfarin does.
- There is a complex exception: for some people with mechanical heart valves, specialists may still individualize a plan that uses warfarin at certain points, because valve clotting risk is life-threatening and the alternatives are not always as protective.
- These are highly specialist decisions made with maternal-fetal medicine and cardiology; the plan is tailored to the person and often to the trimester.
- Never stop or change an anticoagulant on your own; a clot from an untreated condition or a mechanical valve can be life-threatening, so any change must be managed by your care team.
- The old FDA pregnancy letter categories have been retired; questions about a specific exposure can go to MotherToBaby at 1-866-626-6847.
Warfarin is one of the more sensitive medicines to ask about in pregnancy, and the right move is almost always a prompt conversation with your specialist team rather than any decision made alone. Health authorities describe warfarin as a medicine that can harm a developing baby, so it is generally avoided in pregnancy and people are usually switched to a different blood thinner. At the same time, the conditions it treats, such as clots and mechanical heart valves, can be life-threatening if left unprotected, which is why stopping on your own is dangerous. This article gathers what leading U.S. sources say. It is general education only and is not a substitute for medical advice.
What warfarin is and what it treats
Warfarin, sold under names such as Coumadin and Jantoven, is an oral anticoagulant, often called a blood thinner. It works by interfering with vitamin K, which the body needs to make several clotting factors. It is used to prevent and treat dangerous blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and certain heart rhythm problems like atrial fibrillation, and to protect people who have a mechanical (artificial) heart valve, where clot prevention is critical.
Why warfarin is generally avoided in pregnancy
Warfarin is a small molecule that crosses the placenta and reaches the baby, and this is the core of the concern. Medical sources report that exposure during the first trimester can cause a recognizable pattern of birth defects sometimes called warfarin embryopathy or fetal warfarin syndrome. The published literature describes a sensitive window, roughly weeks 6 to 12 of pregnancy, when features such as underdevelopment of the nasal bones and stippling of the developing bones (stippled epiphyses) are most associated with exposure; effects on the central nervous system and eyes, and pregnancy loss, are also described.
The risk later in pregnancy is different but also serious. Because warfarin’s effect is amplified in the baby’s blood, it raises the chance of bleeding in the fetus, which can lead to bleeding in the brain and to pregnancy loss. Whether the risk of birth defects is lower at lower warfarin doses is genuinely debated: some studies suggest lower doses carry less risk, while others report that defects can still occur even at low doses. This uncertainty is one reason the default is to avoid warfarin in pregnancy when a suitable alternative exists.
What clinicians usually do instead
Because the underlying clotting risk still needs to be managed, the standard approach is to switch, not simply to stop. The usual alternatives are heparin or low-molecular-weight heparin (LMWH), given by injection. A key advantage is that these medicines are large enough that they do not cross the placenta the way warfarin does, so they do not carry the same risk of warfarin embryopathy or fetal bleeding. MedlinePlus notes, for example, that people with antiphospholipid syndrome who become pregnant are generally given heparin injections rather than warfarin. For many people who need anticoagulation, a planned switch to heparin-based treatment, ideally before pregnancy or as early as possible, is the route their team takes.
The complex exception: some mechanical heart valves
There is an important and genuinely difficult exception, and it deserves care because it is easy to misread. For some people with a mechanical heart valve, the risk of a clot forming on the valve is extremely high and can be rapidly fatal, and warfarin is often the most effective protection against that. In these situations, published guidance and specialist practice recognize that the injectable alternatives are not always as reliably protective for the valve, so the choice is a balance between a serious risk to the mother and a serious risk to the baby.
Because of this, a maternal-fetal medicine specialist together with a cardiologist may individualize a plan that, in certain circumstances, still uses warfarin during part of the pregnancy, or that uses heparin-based treatment during the highest-risk weeks for the baby and warfarin at other times. The essential point is not to try to work out the right answer alone: this is a highly specialized, individualized decision, built with your cardiology and obstetric team, often trimester by trimester.
The other side: an untreated clot is not safe either
It would be a serious mistake to read “warfarin is avoided” as “anticoagulation is optional.” The conditions warfarin treats can be life-threatening: a clot on a mechanical valve, a pulmonary embolism, or a large vein clot can be fatal to the mother and, in turn, to the pregnancy. Pregnancy itself increases the tendency to clot. That is exactly why the plan is to switch to a pregnancy-appropriate anticoagulant under supervision, never to leave the underlying condition unprotected.
Do not stop or change warfarin on your own
If you take warfarin and are pregnant or planning pregnancy, the safest step is to contact your prescriber and OB promptly, and ideally to plan the switch before conceiving, rather than to stop the tablets on your own. MedlinePlus is explicit that warfarin may harm the fetus and that you should call your doctor right away if you become pregnant while taking it, and equally that you should not stop taking warfarin without talking to your doctor. Suddenly stopping anticoagulation can allow a dangerous clot to form. None of this is a reason for shame; people take warfarin for good reasons, and the right response is a prompt call to your team, not a panicked stop.
A note on the old letter categories
Older references sometimes assigned warfarin an FDA pregnancy “category,” such as D or X. That letter system has been retired. U.S. drug labels now use a narrative format under the Pregnancy and Lactation Labeling Rule. Treat any old letter grade as out of date and rely on current guidance from your specialist team.
Breastfeeding
In general, warfarin is often considered compatible with breastfeeding because very little passes into breast milk. Because this is specific to your situation and overall anticoagulation plan, confirm it with your clinician, and you can also contact MotherToBaby for information on a particular medicine.
When to call your OB or specialist
Reach out to your obstetric provider, cardiologist, and prescriber as early as possible if you take warfarin and are pregnant or planning pregnancy, and right away if you discover you are pregnant while taking it. Seek emergency care for signs of a clot or serious bleeding, such as sudden chest pain, shortness of breath, coughing up blood, a swollen or painful leg, severe headache, one-sided weakness, or heavy or unusual bleeding. For questions about a specific exposure, call MotherToBaby at 1-866-626-6847, a free service on medicines in pregnancy and breastfeeding.
Frequently asked questions
Is warfarin safe to take while pregnant? It is generally avoided because it can cross the placenta and cause a pattern of birth defects with first-trimester exposure and bleeding risks to the baby later on. Most people are switched to heparin or low-molecular-weight heparin by their specialist team.
I took warfarin before I knew I was pregnant. What should I do? Contact your prescriber and OB right away, but do not stop the medicine on your own. Your team will assess your situation, arrange the right monitoring, and plan a switch. MotherToBaby can also answer questions about your specific exposure.
Why might someone with a mechanical heart valve still be on warfarin? Because a clot on a mechanical valve can be rapidly life-threatening and the injectable alternatives are not always as protective, specialists sometimes individualize a plan that uses warfarin at certain points. This is a highly specialized decision made with cardiology and maternal-fetal medicine, not something to arrange alone.
Can I just stop warfarin during pregnancy? No. Stopping anticoagulation on your own can allow a dangerous, potentially fatal clot to form. Any change must be managed by your care team, who will move you to a pregnancy-appropriate plan without leaving you unprotected.
Can I take warfarin while breastfeeding? Warfarin is often considered compatible with breastfeeding because very little passes into milk, but confirm the plan with your clinician, since your overall anticoagulation strategy may involve other medicines too.
This article is general education, not medical advice, and must not be used to start, stop, adjust, or taper any medication on your own. Suddenly stopping some medicines can be dangerous. Always work with the prescriber who manages your care. In an emergency call 911; for mental-health crisis call or text 988.
Sources
- MedlinePlus (U.S. National Library of Medicine) — Warfarin drug information; Antiphospholipid syndrome; Blood thinners / anticoagulants patient pages.
- Peer-reviewed literature indexed on NCBI / PubMed Central on anticoagulation for mechanical heart valves in pregnancy and on fetal warfarin syndrome, describing the sensitive window (about weeks 6–12), the debated dose-related risk, and that low-molecular-weight heparin does not cross the placenta.